Bioequivalence and Bioavailability Forum 17:02 CET

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

ULOQ [Study As­sess­ment]

posted by Anand - India, 2017-10-30 06:38  - Posting: # 17945
Views: 4,513

Dear All,

Request to clarify,

In our Pivotal BE Study ULOQ was observed, whether we should exclude from PK?
After Dilution also it found ULOQ.
Method should be redeveloped or revalidated?
If included,What justification we should provide to Regulatory Agency?

Thanks in advance.

Regards,
A.A


Edit: Category changed; see also this post #1. [Helmut]

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
19,025 posts in 4,058 threads, 1,297 registered users;
online 12 (0 registered, 12 guests [including 7 identified bots]).

[The] impatience with ambiguity can be criticized in the phrase:
absence of evidence is not evidence of absence.    Carl Sagan

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed